GRACE PFEIL: Open Payments
NPI 1588377857 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$821 in 50 payments from 8 companies in 2025. Trend: 2023 $21 · 2024 $438 · 2025 $821
Food & beverage: $821
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 2 | $227 |
| ABBVIE INC. | 24 | $172 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $135 |
| Neurocrine BioSciences, Inc. | 6 | $114 |
| Otsuka America Pharmaceutical, Inc. | 4 | $78 |
| Janssen Pharmaceuticals, Inc | 3 | $52 |
| Teva Pharmaceuticals USA, Inc. | 2 | $30 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
Products named: Auvelity, VRAYLAR, CAPLYTA, INGREZZA, ABILIFY MAINTENA, INVEGA SUSTENNA, UZEDY, REXULTI.
Industry payments across OH — which companies pay providers there.
